StockNews.com started coverage on shares of Aspira Women’s Health (NYSE:AWH – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the stock.
Aspira Women’s Health Stock Performance
AWH stock opened at $3.27 on Tuesday.
About Aspira Women’s Health
(Free Report)
Aspira Women’s Health Inc., together with its subsidiaries, is engaged in developing and commercializing diagnostic tests for gynecologic diseases in the United States. The company’s products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.
See Also
Receive News & Ratings for Aspira Women’s Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aspira Women’s Health and related companies with MarketBeat.com’s FREE daily email newsletter.